In Switzerland, access to cancer drugs can depend on the insurer
Swiss health insurers decide case by case whether to cover medicines outside routine reimbursement. These include drugs prescribed for an unapproved use and drugs that are approved but absent from the list of routinely reimbursed medicines. An evaluation commissioned by the Federal Office of Public Health (FOPH) estimated that about 38,000 new requests were submitted […]
